AlphaCentric Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,000
Closed -$706K 261
2024
Q3
$706K Buy
+14,000
New +$706K 0.52% 59